Charles J. Homcy sold BridgeBio Pharma ($BBIO) shares on the open market three times in the last year, totaling $13.9 million. His most recent sale occurred on August 11, 2025. These sales rank him 887th among 11,678 insiders by value, above the average of $8.6 million across about 6.4 transactions per insider. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 19, 2025 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | J | Common Stock | 1489 | $0.00 | 38,535.0000 | 48,119,444 | 4.02% | 0.00% |
| Oct. 23, 2025 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | G | Common Stock | 28423 | $0.00 | 37,046.0000 | 0 | 43.41% | 0.00% |
| Sept. 22, 2025 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | A | Stock Option (Right to Buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 8, 2025 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Not found | S | Common Stock | 58338 | $46.64 | 966,674.0000 | 190,188,626 | 5.69% | 0.03% |
| Aug. 8, 2025 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Not found | S | Common Stock | 191662 | $45.87 | 1,025,012.0000 | 190,188,626 | 15.75% | 0.10% |
| Aug. 11, 2025 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Not found | S | Common Stock | 50000 | $48.00 | 916,674.0000 | 190,188,626 | 5.17% | 0.03% |
| June 27, 2025 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Not found | G | Common Stock | 20000 | $0.00 | 1,216,674.0000 | 190,188,626 | 1.62% | 0.01% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Not found | A | Stock Option (Right to Buy) | 8425 | $0.00 | 8,425.0000 | 190,188,626 | 9999.99% | 0.00% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Not found | A | Common Stock | 6589 | $0.00 | 1,236,674.0000 | 190,188,626 | 0.54% | 0.00% |
| Dec. 9, 2024 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | A | Stock Option (Right to Buy) | 80385 | $0.00 | 80,385.0000 | 0 | 9999.99% | 0.00% |
| Dec. 9, 2024 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | D | Stock Option (Right to Buy) | 80385 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 9, 2024 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | A | Stock Option (Right to Buy) | 5704 | $0.00 | 5,704.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2025 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | C | Common Stock | 8807 | $0.00 | 44,752.0000 | 0 | 24.50% | 0.00% |
| Feb. 3, 2025 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | C | Common Stock | 20717 | $0.00 | 65,469.0000 | 0 | 46.29% | 0.00% |
| Feb. 3, 2025 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | C | Common Stock | 7422 | $0.00 | 65,469.0000 | 0 | 12.79% | 0.00% |
| Feb. 3, 2025 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | C | Series B Preferred Stock | 72727 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 3, 2025 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | C | Series C Preferred Stock | 169405 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 3, 2025 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | C | Series D-1 Preferred Stock | 71564 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 26, 2024 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | C | Series D-1 Preferred Stock | 71564 | $0.00 | 7,422.0000 | 0 | 0.00% | 0.00% |
| Nov. 26, 2024 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | C | 8% Convertible Note due 2026 | 75000 | $78961.64 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 9, 2024 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | D | Stock Option (Right to Buy) | 5704 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 9, 2024 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | A | Stock Option (Right to Buy) | 46675 | $0.00 | 46,675.0000 | 0 | 9999.99% | 0.00% |
| Dec. 9, 2024 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | D | Stock Option (Right to Buy) | 46675 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 9, 2024 | Maze Therapeutics, Inc. | $MAZE | HOMCY CHARLES J | Not found | A | Stock Option (Right to Buy) | 45638 | $0.00 | 45,638.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2024 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Not found | A | Stock Option (Right to Buy) | 26014 | $0.00 | 26,014.0000 | 0 | 9999.99% | 0.00% |
| Feb. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Not found | F | Common Stock | 1509 | $37.21 | 1,230,085.0000 | 0 | 0.12% | 0.00% |
| Feb. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Not found | M | Common Stock | 3760 | $0.00 | 1,231,594.0000 | 0 | 0.31% | 0.00% |
| Feb. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Not found | M | Restricted Stock Units | 3760 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Director | M | Common Stock | 3760 | $0.00 | 1,228,297.0000 | 0 | 0.31% | 0.00% |
| Nov. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Director | F | Common Stock | 1301 | $28.86 | 1,226,996.0000 | 0 | 0.11% | 0.00% |
| Nov. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Director | M | Restricted Stock Units | 3760 | $0.00 | 3,760.0000 | 0 | 50.00% | 0.00% |
| Aug. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Director | M | Common Stock | 3760 | $0.00 | 1,225,838.0000 | 0 | 0.31% | 0.00% |
| Aug. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Director | F | Common Stock | 1301 | $29.80 | 1,224,537.0000 | 0 | 0.11% | 0.00% |
| Aug. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Director | M | Restricted Stock Units | 3760 | $0.00 | 7,520.0000 | 0 | 33.33% | 0.00% |
| June 21, 2023 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Director | A | Stock Option (right to buy) | 51501 | $0.00 | 51,501.0000 | 0 | 9999.99% | 0.00% |
| May 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Director | M | Common Stock | 3759 | $0.00 | 1,222,127.0000 | 0 | 0.31% | 0.00% |
| May 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Director | F | Common Stock | 1300 | $14.09 | 1,220,827.0000 | 0 | 0.11% | 0.00% |
| May 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Director | M | Restricted Stock Units | 3759 | $0.00 | 11,280.0000 | 0 | 25.00% | 0.00% |
| Feb. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Director | F | Common Stock | 1534 | $12.64 | 1,218,368.0000 | 0 | 0.13% | 0.00% |
| Feb. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Director | M | Common Stock | 3760 | $0.00 | 1,219,902.0000 | 0 | 0.31% | 0.00% |
| Feb. 16, 2023 | BridgeBio Pharma, Inc. | $BBIO | HOMCY CHARLES J | Director | M | Restricted Stock Units | 3760 | $0.00 | 15,039.0000 | 0 | 20.00% | 0.00% |